Marc Struelens
Biographic Data
| ID | 7745032 |
|---|---|
| NAME | Marc Struelens |
| GIVEN NAMES | Marc |
| FAMILY NAME | Struelens |
| SIGNATURE | STRUELENS M |
| AFFILIATIONS | European Centre for Disease Prevention and Control |
| ORCID | 0000-0001-5150-4944 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Covid-19 Research
The response of the scientific community to the COVID-19 pandemic has been unprecedented in size, speed and discovery output. Within months of virus emergence, the SARS-CoV-2 genomics, replication, evolution and dissemination dynamics as well as natural history, infection risk and prognostic factors and biology of the disease have been gradually deciphered. More than 250 articles on COVID-19 published in Frontiers in Public Health have contribute…
Point of Care Testing for Infectious Disease in Europe
Background: Point of care testing (POCT) for infectious diseases is testing conducted near the patient. It allows clinicians to offer the most appropriate treatment more quickly. As POCT devices have increased in accuracy and become more cost-effective, their use has grown, but a systematic assessment of their use for clinical and public health management of infectious diseases in EU/EEA countries has not been previously undertaken. Methods: A sc…
Perceived utility and feasibility of pathogen genomics for public health practice
Belgian health professionals expressed favorable views about implementation of pathogen genomics in their work activities related to infectious disease surveillance and control. They expressed the need for suitable training initiatives to strengthen their competences in the field. Their perception of the utility and feasibility of pathogen genomics for public health purposes will be a key driver for its further implementation
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria
No prominent works on this page.
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria
Perceived utility and feasibility of pathogen genomics for public health practice
Belgian health professionals expressed favorable views about implementation of pathogen genomics in their work activities related to infectious disease surveillance and control. They expressed the need for suitable training initiatives to strengthen their competences in the field. Their perception of the utility and feasibility of pathogen genomics for public health purposes will be a key driver for its further implementation
Covid-19 Research
The response of the scientific community to the COVID-19 pandemic has been unprecedented in size, speed and discovery output. Within months of virus emergence, the SARS-CoV-2 genomics, replication, evolution and dissemination dynamics as well as natural history, infection risk and prognostic factors and biology of the disease have been gradually deciphered. More than 250 articles on COVID-19 published in Frontiers in Public Health have contribute…
Point of Care Testing for Infectious Disease in Europe
Background: Point of care testing (POCT) for infectious diseases is testing conducted near the patient. It allows clinicians to offer the most appropriate treatment more quickly. As POCT devices have increased in accuracy and become more cost-effective, their use has grown, but a systematic assessment of their use for clinical and public health management of infectious diseases in EU/EEA countries has not been previously undertaken. Methods: A sc…
Medicine (4 works) · Public health (3 works) · Antibiotic Use and Resistance (2 works) · Bacterial Identification and Susceptibility Testing (2 works) · Biology (2 works) · Data-Driven Disease Surveillance (2 works) · Disease (2 works) · Family medicine (2 works) · Nursing (2 works) · Pathology (2 works)